Prognostic Factors in Renal Cell Carcinoma: An Evaluation of T-Stage, Histopathological Grade, p53, Ki-67, COX-2, and Her-2 Expressions

QR Code

Prognostic Factors in Renal Cell Carcinoma: An Evaluation of T-Stage, Histopathological Grade, p53, Ki-67, COX-2, and Her-2 Expressions

None

Saved in:

Bibliographic Details
Main Author:	Kankuri-Tammilehto, Minna
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27642
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting Biomarkers of Proliferation and Inflammation (Ki67, p53, and COX-2) in Actinic Keratoses with Photodynamic Therapy
by: Justyna Ceryn, et al.
Published: (2025-06-01)

The importance of prognostic markers of tumor progression Ki-67 and р53 in the breast cancer
by: Bondareva V.A., et al.
Published: (2007-01-01)

PROGNOSTIC SIGNIFICANCE OF Ki67, CYCLOOXYGENASE-2 (COX-2) AND p16ink4a IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-11-01)

Study of Immunohistochemical Expression of p53 and Ki-67 in Oral Squamous Cell Carcinoma
by: Kajal Ranjan, et al.
Published: (2025-08-01)

Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma
by: Alexandra Y Tsidulko, et al.
Published: (2017-09-01)

Immunohistochemical analysis of IDH1, ATRX, p53, and Ki-67 in glioblastoma and diffuse infiltrative glioma: Therapeutic and prognostic correlation
by: Hasbay Bermal, et al.
Published: (2025-01-01)

Correlation of Ki-67 Expression with the Stage of Disease in Patients of Colorectal Carcinoma
by: Ashutosh Nagpal, et al.
Published: (2025-07-01)

The Significance of the Ki-67 Labeling Index, the Expression of c-kit, p53, and bcl-2, and the Apoptotic Count on the Prognosis of Gastrointestinal Stromal Tumor
by: Aoyagi, Keishiro, et al.
Published: (2012)

Cyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study
by: Alper Sinanoglu, et al.
Published: (2015-06-01)

Comparative immunohistochemical study of ki-67, p53, caspase-3 in distal colonic polyps and colorectal adenocarcinoma.
by: M. A. Shyskin
Published: (2019-09-01)

Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapy
by: Dumanskij Yu.V., et al.
Published: (2008-01-01)

Comparison of immunohistochemical characteristics of expression estrogen receptors-alpha, progesterone receptors, p16, p53, Ki-67 and caspase 3 in invasive endometrial adenocarcinoma of different grade.
by: V. A. Tumanskiy, et al.
Published: (2016-09-01)

Characterization and analysis of Ki-67-immunoreactivity in brain astrocytoma
by: Shpon‘ka I.S., et al.
Published: (2016-03-01)

Characterization and analysis of Ki-67-immunoreactivity in brain astrocytoma.
by: I. S. Shpon‘ka, et al.
Published: (2016-04-01)

Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma
by: Faris Durmo, et al.
Published: (2025-05-01)

BIOLOGICAL MARKERS OF THE Ki-67 CELL CYCLE AND Bcl-2 IN MYOMA, ADENOMYOSIS, AND LEIOMYOSARCOMA UTERI
by: Светлана Владимировна Шрамко, et al.
Published: (2019-09-01)

Immunoexpression of P16 and Ki 67 in oral squamous cell carcinoma: Association with clinicopathological parameters.
by: Shadan Mohamad Omer, et al.
Published: (2020-12-01)

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.
by: Yuejun Tian, et al.
Published: (2016-01-01)

Blood biomarkers and Ki-67 proliferation marker in breast cancer
by: A. A. Studenikina, et al.
Published: (2023-04-01)

Prognostic relevance of Ki-67 and P16/INK4a markers in histological diagnosis of cervical dysplasia
by: T. A. Dimitriadi, et al.
Published: (2020-03-01)

PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF KI67 DYNAMIC CHANGE DURING PREOPERATIVE ENDOCRINE THERAPY IN BREAST CNACER PATIENTS
by: M. V. Rodionova, et al.
Published: (2016-02-01)

Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker
by: Jianjun Wang, et al.
Published: (2017-06-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
by: T. A. Bogush, et al.
Published: (2023-07-01)

CRP/albumin ratio and WBC values correlate with Ki-67 and survival in glioblastoma multiforme
by: Güven Gürsoy
Published: (2025-06-01)

Prognostic value of serum NLR, PLR, P53, K67 level in lymph node metastasis of early gastric cancer
by: Long Xin, et al.
Published: (2025-01-01)

ASSOCIATION BETWEEN APPARENT DIFFUSION COEFFICIENT AND KI67 IN BRAIN TUMORS: A SYSTEMATIC REVIEW
by: I. A. Stepanov, et al.
Published: (2021-05-01)

Tumor Ki-67, ER and PR, and antibodies against estradiol and progesterone in breast cancer patients
by: A. N. Glushkov, et al.
Published: (2023-09-01)

CD117 and Ki-67 expression in gastrointestinal stromal tumors of various morphological variants and localization
by: Shpon’ka I.S., et al.
Published: (2014-03-01)

A Case of a Rapidly Progressive Small Bowel Lymphoma with High Ki-67 Expression
by: Jiyeon Yoo, et al.
Published: (2017-03-01)

ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment
by: A Ianza, et al.
Published: (2020-06-01)

The Role of COX-2 Inhibitors on Experimental Colitis
by: Paiotti, Ana Paula R., et al.
Published: (2012)

The Enigmatic Odontogenic Keratocyst: A Cross-sectional Study of Odontogenic Cysts and Tumors Using Ki-67
by: Pretty Prince Panakkal, et al.
Published: (2025-07-01)

Prognostic value of complex assessment of Ki-67, tumor necrosis factor α, CD20 and CD31 expression in non-small cell lung cancer
by: O. V. Kovaleva, et al.
Published: (2021-12-01)

Comparison of machine learning and Cox regression models for prognostic analysis in hepatocellular carcinoma patients with distant metastasis
by: Hailan Li, et al.
Published: (2025-09-01)

NUCLEAR ORGANIZERS IN KI-67 POSITIVE CELLS OF SQUAMOUS CELL LUNG CANCER: CLINICAL MORPHOLOGICAL PARALLELS AND SURVIVAL
by: D. S. Kobyakov, et al.
Published: (2016-02-01)

MRI-based multiregional radiomics for preoperative prediction of Ki-67 expression in meningiomas: a two-center study
by: Ming Luo, et al.
Published: (2025-07-01)

Association of p53 codon 72 polymorphisms with expression status of hormone receptors like ER, PR, and HER-2 in invasive ductal breast carcinoma in Bangladeshi women
by: Md. Zillur Rahman, et al.
Published: (2025-07-01)

Proliferation in Minimal Invasive Samples of Canine Lymphomas: Ki67 Index in Previously Stained Cytology and Paired Cell Blocks
by: Filipe Sampaio, et al.
Published: (2025-06-01)

Evaluating feature selection methods in a hybrid Weibull Freund-Cox proportional hazards model for renal cell carcinoma
by: Shaymaa Mohammed Ahmed, et al.
Published: (2025-08-01)

Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case report
by: Hiromi Nagata, et al.
Published: (2020-01-01)